Borges, O., Silva, M., de Sousa, A., Borchard, G., et al. (2008). Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen. International Immunopharmacology, 8(13-14), 1773 - 1780.

Borges, O., Cordeiro-da-Silva, A., Tavares, J., Santarém, N., et al. (2008). Immune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics, 69(2), 405 - 416.

Borges, O., Tavares, J., de Sousa, A., Borchard, G., et al. (2007). Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles. European Journal of Pharmaceutical Sciences, 32(4-5), 278 - 290.

Borges, O., Borchard, G., de Sousa, A., Junginger, H. E., & Cordeiro-da-Silva, A. (2007). Induction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymers. International Journal of Pharmaceutics, 337(1-2), 254 - 264.

Borges, O., Cordeiro-da-Silva, A., Romeijn, S. G., Amidi, M., et al. (2006). Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination. Journal of Controlled Release, 114(3), 348 - 358.